First Time Loading...

ADC Therapeutics SA
NYSE:ADCT

Watchlist Manager
ADC Therapeutics SA Logo
ADC Therapeutics SA
NYSE:ADCT
Watchlist
Price: 4.37 USD -0.46%
Updated: Apr 16, 2024

EBITDA Margin
ADC Therapeutics SA

-234.6%
Current
-843%
Average
-4.3%
Industry
Negative for the last year
-234.6%
Negative average
-843%
Better than average
Worse than industry value

EBITDA Margin Across Competitors

EBITDA Margin Comparison
ADC Therapeutics SA Competitors

Country Company Market Cap EBITDA
Margin
CH
ADC Therapeutics SA
NYSE:ADCT
360.7m USD
-235%
US
Abbvie Inc
NYSE:ABBV
285.5B USD
46%
US
Amgen Inc
NASDAQ:AMGN
142.2B USD
43%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
102.4B USD
41%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
98.3B USD
35%
AU
CSL Ltd
ASX:CSL
134.6B AUD
32%
US
Gilead Sciences Inc
NASDAQ:GILD
84.4B USD
40%
US
Seagen Inc
NASDAQ:SGEN
43.1B USD
-29%
US
Moderna Inc
NASDAQ:MRNA
39.7B USD
-53%
US
Biogen Inc
NASDAQ:BIIB
28.5B USD
26%
IE
Horizon Therapeutics PLC
NASDAQ:HZNP
26.6B USD
26%
ADC Therapeutics SA
NYSE:ADCT
Country CH
Market Cap 360.7m USD
EBITDA Margin
-235%
Abbvie Inc
NYSE:ABBV
Country US
Market Cap 285.5B USD
EBITDA Margin
46%
Amgen Inc
NASDAQ:AMGN
Country US
Market Cap 142.2B USD
EBITDA Margin
43%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Country US
Market Cap 102.4B USD
EBITDA Margin
41%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Country US
Market Cap 98.3B USD
EBITDA Margin
35%
CSL Ltd
ASX:CSL
Country AU
Market Cap 134.6B AUD
EBITDA Margin
32%
Gilead Sciences Inc
NASDAQ:GILD
Country US
Market Cap 84.4B USD
EBITDA Margin
40%
Seagen Inc
NASDAQ:SGEN
Country US
Market Cap 43.1B USD
EBITDA Margin
-29%
Moderna Inc
NASDAQ:MRNA
Country US
Market Cap 39.7B USD
EBITDA Margin
-53%
Biogen Inc
NASDAQ:BIIB
Country US
Market Cap 28.5B USD
EBITDA Margin
26%
Horizon Therapeutics PLC
NASDAQ:HZNP
Country IE
Market Cap 26.6B USD
EBITDA Margin
26%

Profitability Report

View the profitability report to see the full profitability analysis for ADC Therapeutics SA.

Full Profitability Report

See Also

Summary
ADCT intrinsic value, competitors valuation, and company profile.
DCF Valuation
ADCT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ADCT stock valuation using valuation multiples.
Wall Street Estimates
ADCT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ADCT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is EBITDA Margin?
What is the EBITDA Margin of ADC Therapeutics SA?

Based on ADC Therapeutics SA's most recent financial statements, the company has EBITDA Margin of -234.6%.

ALPHA SPREAD
Join more than 128,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.